• Home
  • Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.

Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.

Author List
Koren J, Miyata Y, Kiray J, O'Leary JC, Nguyen L, Guo J, Blair LJ, Li X, Li X, Jinwal UK, Cheng JQ, Gestwicki JE, Dickey CA
Publication
PloS one
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1162088
Publication Year
2012
PubMed ID
22563386
Publication Title
Koren J, Miyata Y, Kiray J, O'Leary JC, Nguyen L, Guo J, Blair LJ, Li X, Li X, Jinwal UK, Cheng JQ, Gestwicki JE, Dickey CA. Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance. PLoS One. 2012; 7(4):e35566.